Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

Abroad (travel likely)RecruitingPHASE2

Conditions

Asthma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Michael Wechsler, MD

    Principal Investigator

    National Jewish Health